Investment Rating - The report maintains an "Outperform" rating for the company [1] Core Views - The company continues to show growth potential in the Asia-Pacific region, with a significant increase in orders from Chinese automakers [3] - The company's revenue for the first half of 2024 was USD 2.10 billion, a slight decrease of 0.1% YoY, but gross margin improved by 1.0 percentage points to 10.0% [3] - Net profit attributable to shareholders decreased by 53.8% YoY to USD 20 million, with a net profit margin of 0.7%, down 0.9 percentage points YoY [3] - The company successfully launched 38 new customer projects in the first half of 2024, with nearly half being pure EV projects [3] - New orders in the first half of 2024 amounted to USD 2.1 billion, with Chinese automakers contributing 43% of the total [3] Financial Performance Revenue Breakdown by Product - Electric Power Steering (EPS) product sales revenue was USD 1.40 billion, down 2.6% YoY [3] - Steering Column and Intermediate Shaft (CIS) product sales revenue was USD 220 million, up 18% YoY [3] - Hydraulic Power Steering (HPS) product sales revenue was USD 90 million, up 5.3% YoY [3] - Driveline (DL) product sales revenue was USD 380 million, down 0.8% YoY [3] Revenue Breakdown by Region - North America revenue was USD 1.12 billion, down 6.3% YoY [3] - Asia-Pacific revenue was USD 590 million, up 9.3% YoY [3] - Europe, Middle East, Africa, and South America revenue was USD 370 million, up 1.4% YoY [3] - Other regions contributed USD 20 million [3] Financial Forecast - Revenue is expected to be USD 4.5 billion, USD 5.0 billion, and USD 5.9 billion for 2024, 2025, and 2026, respectively [3] - Net profit attributable to shareholders is forecasted to be USD 101 million, USD 237 million, and USD 313 million for 2024, 2025, and 2026, respectively [3] - EPS is projected to be USD 0.04, USD 0.09, and USD 0.12 for 2024, 2025, and 2026, respectively [3] Valuation - The company is valued at 11-13x PE for 2024, with a fair value range of HKD 3.44-4.07 (converted at HKD 1 ≈ USD 0.13) [3] Comparable Companies - Comparable companies include Bethel (603596 SH) and Top Group (601689 SH), with average PE ratios of 22x, 17x, and 19x for 2022, 2023, and 2024E, respectively [5] Financial Statements Income Statement - Revenue for 2023 was USD 4.21 billion, with a YoY growth of 10% [4] - Net profit attributable to shareholders for 2023 was USD 37 million, a decrease of 37% YoY [4] - EPS for 2023 was USD 0.01 [4] Balance Sheet - Total assets for 2023 were USD 3.41 billion, with current assets at USD 1.55 billion and non-current assets at USD 1.86 billion [7] - Total liabilities for 2023 were USD 1.39 billion, with current liabilities at USD 1.09 billion and non-current liabilities at USD 305 million [7] - Shareholders' equity for 2023 was USD 2.01 billion [7] Cash Flow Statement - Operating cash flow for 2024E is projected to be USD 404 million [6] - Net cash flow for 2024E is expected to be USD 57 million [6] Key Financial Ratios - Gross margin for 2023 was 8.76%, expected to increase to 10.70% in 2024E [6] - Net profit margin for 2023 was 0.87%, expected to rise to 2.22% in 2024E [6] - ROE for 2023 was 1.87%, projected to increase to 4.89% in 2024E [6] - ROIC for 2023 was 2.07%, expected to rise to 5.46% in 2024E [6]

[Table_MainInfo] 公司研究/汽车与零配件/汽车 证券研究报告 零跑汽车（9863）公司公告点评 2024 年 08 月 16 日 股票数据 8[T月ab15le日_S收t盘oc价kI（nf港o币] ） 22.65 52 周股价波动（港币） 19.60-45.00 总股本/流通 A 股（百万股） 1337/1116 总市值/流通市值（百万港币） 30282/25287 [《Ta零b跑le汽_R车e（p0o9r8t6In3f）o]：厚积薄发，轻资产出 《零跑 C16 正式上市，新车起售价 15.58 万 《Q1 营收同比翻倍，轻资产出海稳步推进》 [Table_QuoteInfo] | --- | |------------------------| | 相关研究 | | 海加速推进》2024.07.16 | | 元》2024.07.02 | | 2024.05.31 | | 市场表现 | 沪深 300 对比 1M 2M 3M [Table_AuthorInfo] | --- | --- | --- | --- | |---------------|-------|-------|-------| ...

Investment Rating - The report assigns an "Outperform" rating to the company, indicating a positive outlook for its stock performance [1] Core Views - The company is a leading producer of high-quality anthracite coal in Shanxi Province, with a well-established coal-chemical integration strategy that enhances its competitive advantage [5] - The coal business is expected to see volume growth and stable prices, supported by increasing production capacity and high-quality resources [5] - The coal-chemical integration and strong brand recognition in urea and caprolactam products are expected to drive profit improvements [5] - The company has a healthy asset structure and has initiated quarterly dividends, reflecting confidence in future growth [6] Company Overview - The company is the first listed coal enterprise in Shanxi Province, with a diversified business model integrating coal, chemical, and fertilizer industries [13] - It operates in the Qinshui Coalfield, the largest anthracite coal base in China, with significant resource reserves [13] - The company has a total coal production capacity of 19.9 million tons, including 14.1 million tons of in-production capacity and 4 million tons of equity capacity [13] - The company's "Lanhua" brand anthracite coal is known for its high calorific value, mechanical strength, and low ash and sulfur content [13] Coal Business - The company's coal production capacity is 19.9 million tons, with 14.1 million tons of in-production capacity and 4 million tons of equity capacity [23] - Coal production increased by 20% in 2023, with a capacity utilization rate of 98% [27] - The company's coal sales reached 12.99 million tons in 2023, with anthracite accounting for 74.7% of total sales [31] - The average selling price of coal in 2023 was 740 yuan/ton, while the production cost remained stable at around 250-290 yuan/ton [33] Coal-Chemical Integration - The company has a urea production capacity of 1 million tons, with actual production of 967,800 tons in 2023 [42] - Urea sales increased by 19% in 2023, driven by rising demand and falling coal prices [44] - The company's caprolactam production capacity is 140,000 tons, with actual production of 101,000 tons in 2023 [57] - Caprolactam sales decreased by 19.63% in 2023 due to weak market demand [58] Financial Performance - The company's revenue in 2023 was 13.28 billion yuan, a decrease of 6.2% year-on-year, while net profit was 2.098 billion yuan, a decrease of 34.9% year-on-year [22] - The company's gross margin in 2023 was 41.7%, down from 54.5% in 2022 [7] - The company's operating cash flow in 2023 was 2.673 billion yuan, a decrease of 53.1% year-on-year [64] Dividend Policy - The company has a dividend policy that ensures cash dividends of no less than 30% of the annual net profit attributable to shareholders [6] - In 2023, the company distributed a total of 1.42 billion yuan in dividends, with a dividend payout ratio of 53.1% [6]

[Table_MainInfo] 公司研究/商业贸易/专营零售 证券研究报告 小商品城（600415）公司跟踪报告 2024 年 08 月 16 日 [Table_InvestInfo] 投资评级 优于大市 维持 股票数据 | --- | --- | |---------------------------------------------|----------------| | 08[Table_StockInfo 月 15日收盘价（元）] | 7.48 | | 52 周股价波动（元） | 6.78-10.09 | | 总股本/流通 A 股（百万股） | 5484/5470 | | 总市值/流通市值（百万元） | 41023/40912 | | 相关研究 | | | [Table_ReportInfo] 《1Q24 主业净利大增 102% | ，分红率提升》 | | 2024.04.21 | | | 《如何看小商品城的业务结构和市值空间》 | | | 2024.03.18 | | | 《小商品城深度报告：从蛰伏到蝶变，综合贸 | | | 易服务商转型步入收获期》 | 2024.03.04 | | 市场表现 ...

[Table_MainInfo]行业研究/交通运输/航空公司 证券研究报告 行业跟踪报告 2024 年 08 月 16 日 [Table_InvestInfo] 投资评级 优于大市 维持 市场表现 [Table_QuoteInfo] 航空公司 海通综指 -20.83% -15.70% -10.58% -5.45% -0.33% 4.80% 2023/8 2023/11 2024/2 2024/5 资料来源：海通证券研究所 相关研究 [Table_ReportInfo] 《6 月行业供给环比收紧，客座率改善》 2024.07.22 《5月行业供需环比回升，需求逐步修复》 2024.06.21 《4 月行业需求有所回落》2024.05.22 分析师:陈宇 Tel:(021)23185610 Email:cy13115@haitong.com 证书:S0850520060002 分析师:虞楠 Tel:(021)23219382 Email:yun@haitong.com 证书:S0850512070003 7 月行业供需同比改善，客座率明显提升 [Table_Summary] 投资要点： 7 月行业供需同比大幅上升 ...

Investment Rating - The investment rating for the company is "Outperform the Market" and is maintained [2] Core Views - The report highlights the growth potential brought by the new projects in Inner Mongolia, with a significant increase in revenue and net profit [5][6] - The company achieved a revenue of 16.897 billion yuan in H1 2024, representing a year-on-year growth of 29.09%, and a net profit of 3.516 billion yuan, up 44.37% year-on-year [5][6] Summary by Sections Financial Performance - In H1 2024, the company reported a revenue of 16.897 billion yuan, a 29.09% increase year-on-year, and a net profit of 3.516 billion yuan, reflecting a 44.37% growth year-on-year [5][6] - The sales revenue for various products showed significant changes: polyethylene and polypropylene sales increased by 69.25% and 75.48% respectively, while sales of coke and pure benzene decreased by 3.40% and 28.90% [6] - The gross profit margin and net profit margin improved by 5.80 and 2.32 percentage points to 33.60% and 19.56% respectively [6] Project Development - The company is making steady progress on new projects, with the Ningdong Phase III Olefin Project starting trial production in mid-September 2023 and the Inner Mongolia Olefin Project on track for completion [6] - The Inner Mongolia project has completed 70% of its investment, with the first boiler successfully ignited on July 1, 2024, marking a significant milestone [6] Cost Management - The company has optimized its energy consumption, achieving the lowest energy consumption levels in the coal-to-olefin industry, with a reduction of 2.73% in methanol consumption and 4.22% in polyolefin products [6] - The proportion of coal sourced from Xinjiang has increased by nearly 7 percentage points, contributing to lower coal costs [6] Earnings Forecast - The company is expected to have EPS of 1.17, 1.46, and 1.76 yuan for 2024-2026, with a reasonable valuation range of 18.72-21.06 yuan based on a PE ratio of 16-18 times [7][8]

[Table_MainInfo]行业研究/建筑工程 证券研究报告 行业月报 2024 年 08 月 16 日 [Table_InvestInfo] 投资评级 优于大市 维持 市场表现 [Table_QuoteInfo] -23.45% -18.04% -12.63% -7.22% -1.81% 3.60% 建筑工程 海通综指 2023/8 2023/11 2024/2 2024/5 资料来源：海通证券研究所 相关研究 [Table_ReportInfo] 《专业工程 Q2 单季订单保持稳健增长》 2024.08.04 《专业工程受益设备更新/先导产业加 速》2024.07.28 《重点推荐中国化学、柏诚股份》 2024.07.22 分析师:张欣劼 Tel:(010)58067906 Email:zxj12156@haitong.com 证书:S0850518020001 联系人:陈默婧 Tel:(021)23183263 Email:cmj16245@haitong.com 月度跟踪-7 月基建投资放缓，对外承包工 程新签持续高增 [Table_Summary] 投资要点： 下游及前瞻指标——广义、狭义基建投 ...

Investment Rating - The investment rating for the company is "Outperform the Market" and is maintained [1][6]. Core Views - The report anticipates that the profitability of the cement industry will turn positive year-on-year in Q3 2024. The company expects a net profit attributable to shareholders of 160 to 180 million yuan in the first half of 2024, reflecting a year-on-year decline of 66.13% to 69.89%. The main reasons for the profit decline in the first half of 2024 are the drop in both sales volume and prices of cement products due to market imbalance. However, from June 2024, the price difference between cement and coal is expected to gradually recover, which may positively impact industry profitability [5][6]. Summary by Sections Financial Performance - The company's revenue for 2023 is projected at 6,397 million yuan, with a year-on-year decrease of 10.3%. The net profit is expected to be 744 million yuan, down 21.6% year-on-year. The earnings per share (EPS) for 2024 is estimated at 0.54 yuan, with a projected gross margin of 26.7% [7][10]. Business Strategy - The company is implementing a "one main, two wings" strategy, focusing on cement and building materials as the main business while expanding into aggregate, environmental logistics, and new economic investments. The company has significantly increased its fixed assets from 2.65 billion yuan in 2019 to 5.13 billion yuan in Q1 2024, with substantial growth in cement production capacity [5][6]. Shareholder Returns - The company has increased its dividend payout ratio to 51.4% in 2023 and announced a share buyback plan of 100 to 200 million yuan in June 2024, indicating a proactive approach to returning value to shareholders [6][10]. Valuation - The report estimates the company's EPS for 2024 to be 0.54 yuan, with a price-to-earnings (P/E) ratio of 14 to 16 times, suggesting a reasonable value range of 7.56 to 8.64 yuan per share [6][9].

Industry Investment Rating - The report maintains an "Outperform" rating for the industry [1] Core Views - The "engineer dividend" has been a core advantage for Chinese CXO companies in global competition, but India's growing higher education scale and population are gradually revealing its own "engineer dividend" [2] - The "China+1" strategy is driving the development of India's pharmaceutical industry, with the Indian government aiming for the pharmaceutical industry to reach $130 billion by 2030 and $450 billion by 2047 [2] - Indian CDMO companies are smaller in scale compared to their global peers, but they benefit from a large pool of low-cost, highly educated talent [2] - Syngene, India's first CRO company, has shown strong performance with a 17% YoY revenue growth in FY2023 and a 15% CAGR in EBITDA from 2016-2023 [2] - Despite the "China+1" strategy, Indian CDMO companies are not yet able to effectively replace their Chinese counterparts due to significant gaps in revenue scale, employee numbers, and infrastructure investment [3] Comparison of Indian and Chinese CXO Companies - Indian CXO companies have significantly smaller revenue scales compared to Chinese companies, with leading Chinese companies like WuXi AppTec and Pharmaron generating revenues of $40.3 billion and $11.5 billion respectively in 2023 [5] - Indian CDMO companies have shown revenue growth with a CAGR of 10-20% from 2019-2023, but their revenue scales remain much smaller than their Chinese counterparts [5] Indian CDMO Industry Overview - The Indian CDMO industry has seen overall revenue growth with a CAGR of 10-20% from 2019-2023, with CDMO business accounting for over 40% of revenue [11] - North America and Europe are the primary sources of revenue for Indian CDMO companies, with Syngene deriving 72% of its revenue from the US and Laurus deriving 48% from Europe [11] - Indian CDMO companies have lower median employee salaries, averaging $7,900 annually, which is significantly lower than their global peers [14] - The rapid expansion of India's higher education system has provided a large pool of highly educated talent, but concerns remain about the quality of education due to the speed of expansion [16] Syngene International Ltd - Syngene, India's first CRO company, was established in 1994 and went public in 2015, showing strong performance with a 17% CAGR in revenue from 2016-2023 [18] - Syngene's EBITDA margin has remained above 30%, with a net profit margin that is competitive within the industry [22] - The company has a high proportion of scientists, with over 6,000 scientists accounting for 70% of its workforce, and over 80% of its scientists hold master's or doctoral degrees [24] - Syngene's CDMO business has grown significantly, with revenue doubling over five years and accounting for 40% of total revenue in FY2024 Q3 [31] - The company has a diverse client base, with 72% of its clients coming from the US and 15% from Europe [33] - Syngene has established long-term partnerships with major multinational corporations like Amgen, Baxter, and BMS, with whom it has built dedicated R&D centers [35] Indian Government Policies and Industry Support - The Indian government has introduced several policies to support the pharmaceutical industry, including the Production Linked Incentive (PLI) schemes and the India@100 vision, aiming for the pharmaceutical industry to reach $130 billion by 2030 and $450 billion by 2047 [8][9] - The PLI schemes provide financial incentives for bulk drug production and high-value pharmaceutical manufacturing, with a total investment of 1,500 billion INR over six years [9]

[Table_MainInfo]行业研究/机械工业 证券研究报告 行业月报 2024 年 08 月 15 日 [Table_InvestInfo] 投资评级 优于大市 维持 市场表现 [Table_QuoteInfo] 资料来源：海通证券研究所 相关研究 [Table_ReportInfo] 《中央指导加快经济绿色转型，重视新能 源领域发展机会》2024.08.13 《三部门制定行动方案加快构建新型电 力系统，特高压、配网等为电网重点投资 领域》2024.08.12 《7 月新能源车产销量同比向上，关注新 技术进展及海外锂电扩产情况》 2024.08.12 分析师:赵玥炜 Tel:(021)23219814 Email:zyw13208@haitong.com 证书:S0850520070002 分析师:赵靖博 Tel:(021)23185625 Email:zjb13572@haitong.com 证书:S0850521100001 联系人:欧阳天奕 Tel:(021)23183327 Email:oyty16226@haitong,com 叉车月度跟踪：7 月总销量同比+11.5%， 出口销量同比+21. ...